Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis.  McCormack L, Ponce J, Chatterjee A, Tan JK.  JAAD Case Rep. 2021 Jan 11;10:22-24. doi: 10.1016/j.jdcr.2020.12.031. PMID: 33732840; PMCID: PMC7941000. https://www.nc…

Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists.  Thakrar AP, Jablonski L, Ratner J, Rastegar DA.  J Addict Med. 2021 Mar 19. doi: 10.1097/ADM.0000000000000838. Epub ahead of print. PMID: 33758112…

SUBOXONE® Sublingualfilm ist jetzt für die Behandlung der Opioidabhängigkeit verfügbar Mannheim - Indivior (INDV) gab heute bekannt, dass Suboxone® Sublingualfilm (Buprenorphin und Naloxon) jetzt in Deutschland für die Substitutionstherapie bei Opi…

The administration of the opioid buprenorphine decreases motivational error signals D.M. Pfabigan, M. Rütgen, S.L. Kroll, I. Riečanský, C. Lamm, Psychoneuroendocrinology, 2021, 105199, ISSN 0306-4530, doi.org/10.1016/j.psyneuen.2021.105199. In Pre…

RBP-6000: a rationally designed prolonged-release buprenorphine formulation Authors: Wiest K., Shaya G., Somaini L., and Greenwald M. Summary: Background. RBP-6000 (Sublocade®; Subutex Prolonged Release Solution for Injection®) is a monthly prolon…

Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial.  Wong JSH, Nikoo M, Westenberg JN, Sue…